Group 1: Elauwit Connection (ELWT) - Elauwit Connection plans to raise $15 million by issuing 1.67 million shares at a price of $9 per share, reflecting the company's valuation and market sentiment towards the broadband sector [2] - The company focuses on multi-family residential broadband services, offering a comprehensive service system that includes network design, project management, installation, and maintenance, which is a key competitive advantage [2] - For the first half of 2025, Elauwit Connection reported revenue of $11.69 million but incurred a net loss of $380,000, which is common for companies in the expansion phase due to high initial investments [3] Group 2: Innocan Pharma - Innocan Pharma, already listed in Canada, aims to raise $15.19 million by issuing 1.09 million shares at a price of $13.962 per share, indicating market confidence in its pharmaceutical business [4] - The company specializes in chronic pain management, focusing on the development and sale of CBD-related drugs, utilizing LPT-CBD technology to enhance drug efficacy [4] - In the first half of 2025, Innocan Pharma achieved revenue of $14.80 million but faced a net loss of $540,000, which is attributed to the high costs associated with drug development and market promotion [5] Group 3: Buda Juice (BUDA) - Buda Juice plans to raise between $20 million and $24 million by issuing 2.67 million shares at a price range of $7.5 to $9 per share, making it the largest fundraising effort among the three companies [6] - The company operates in the juice industry, focusing on citrus beverages and has developed an end-to-end cold chain platform to ensure product freshness, which provides a competitive edge [7] - For the first half of 2025, Buda Juice reported revenue of $6.55 million and achieved a net profit of $1.98 million, making it the only profitable company among the three, showcasing strong cost control and business profitability [7]

Buda Juice成立于2013年，在截至2025年6月30日的12个月内实现了1200万美元营收。公司计划在纽约证 券交易所(NYSE)挂牌上市，股票代码为"BUDA"。MDB资本集团(MDB Capital Group)是此次发行的独 家主承销商。 Buda Juice表示，公司正通过端到端冷链平台开创"超鲜"(UltraFresh)果汁品类。其产品组合涵盖多个品 牌线及零售客户的鲜榨柑橘汁与健康饮剂，公司认为这一布局既体现了品牌多元化优势，也彰显了代工 生产能力。目前，该公司的生产基地位于达拉斯，同时计划于2026年在南卡罗来纳州、2027年在亚利桑 那州/内华达州新建生产设施。 美国主营自有品牌及代工柑橘类饮品的Buda Juice(BUDA.US)于周一公布了其首次公开发行(IPO)条款。 这家总部位于得克萨斯州达拉斯市的公司计划通过发行270万股股票(其中25%为二次发售股份)筹集2200 万美元，发行价格区间为每股7.50美元至9.00美元。若按该区间中间价计算，Buda Juice的市值将达到 9900万美元。 ...